(Q34387479)

1 August 2017

title

Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate (English)

1 reference

1 August 2017

0 references

1 reference

ChEBI release 2020-05-28

ChEBI ID

15891

author

Mark Frederick McCarty

series ordinal

1

object named as

McCarty MF

1 reference

1 August 2017

publication date

1 February 1996

1 reference

1 August 2017

1 reference

1 August 2017

volume

46

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

89-100

1 reference

Magnesium interrelationships in ischemic heart disease: a review

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Observations in experimental magnesium depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of dietary magnesium on sodium-potassium pump action in the heart of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium deficiency and refractioriness to potassium repletion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Sudden-death ischemic heart disease and dietary magnesium intake: Is the target site coronary vascular smooth muscle?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

PLATELETS, MAGNESIUM, AND MYOCARDIAL INFARCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Prevention of thrombosis in microvascular surgery by the use of magnesium sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Intravenous magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Serum magnesium levels in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Molecular mechanisms of platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Protein kinase C: mediator or inhibitor of insulin action?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium Deficiency in Patients on Long-Term Diuretic Therapy for Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effect of magnesium on blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of Oral Magnesium on Blood Pressure and Red Cell Sodium Transport in Patients Receiving Long-term Thiazide Diuretics for Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Oral magnesium supplementation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Long-term magnesium supplementation in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Heart-muscle magnesium, potassium, and zinc concentrations after sudden death from heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of magnesium-deficient diet upon puppies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Hypomagnesaemia in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Daily magnesium supplements improve glucose handling in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Hypomagnesemia in relation to diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Regression of atherosclerosis. A role for calcium antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Insulin increases vascular smooth muscle recovery from intracellular calcium loads.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Magnesium bioavailability from magnesium citrate and magnesium oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Physiological actions of taurine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine: an overview of its role in preventive medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Regulation of calcium transport in drug-induced taurine-depleted hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Interaction of taurine with methionine: inhibition of myocardial phospholipid methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The action of taurine on chloride conductance and excitability characteristics of rat striated muscle fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of taurine on alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The treatment of myotonia: Evaluation of chronic oral taurine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Inhibition of Na+-Ca2+ exchange in heart sarcolemmal vesicles by phosphatidylethanolamine N-methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The mechanism of the adrenergic stimulation of taurine influx in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine concentrations in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Usefulness of taurine in chronic congestive heart failure and its prospective application

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Beneficial effect of taurine in rabbits with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The myocardium in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The protective effects of taurine on hypoxia (performed in the absence of glucose) and on reoxygenation (in the presence of glucose) in guinea-pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine modulates platelet aggregation in cats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effect of taurine on arterial, uterine and cardiac PGI2 and TXA2 synthesis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of taurine on rat aorta in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The effect of taurine on high potassium-and noradrenaline-induced contraction in rabbit ear artery

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine antagonizes the increase in intracellular calcium concentration induced by alpha-adrenergic stimulation in freshly isolated guinea-pig cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effect of dietary taurine on blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Retardation of the development of hypertension in DOCA salt rats by taurine supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The effects of taurine on atherosclerosis development in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine protection against experimental arterial calcinosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Potentiation of the actions of insulin by taurine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Hypoglycemic properties of taurine: not mediated by enhanced insulin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine binding to the purified insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Protein glycation and oxidative stress in diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Potential clinical applications for high-dose nutritional antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Early platelet consumption in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Lipid peroxidation in pregnancy: new perspectives on preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Cerebral vasoconstriction in toxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Action of magnesium sulfate in the treatment of preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

Taurine- and penicillin-induced epileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

The Current Status of Taurine in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2896%2990007-9

7 January 2021

10.1016/S0306-9877(96)90007-9

Identifiers

DOI

1 reference

1 August 2017

1 reference